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Abstract: BACKGROUND The benefits of extracorporeal membrane oxygenation (ECMO) in children
with sepsis remain controversial. Current guidelines on management of septic shock in children recom-
mend consideration of ECMO as salvage therapy. We sought to review peer-reviewed publications on
effectiveness of ECMO in children with sepsis. METHODS Studies reporting on mortality in children
with sepsis supported with ECMO, published in PubMed, Scopus and Embase from 1972 till February
2020, were included in the review. This study was done in adherence to Preferred Reporting Items for
Systematic Review and Meta-Analysis statement after registering the review protocol with PROSPERO.
Study eligibility was independently assessed by two authors and disagreements resolved by a third author.
Publications were reviewed for quality using Grading of Recommendations Assessment, Development, and
Evaluation (GRADE) system. Random-effects meta-analyses (DerSimonian and Laird) were conducted,
and 95% confidence intervals were computed using the Clopper-Pearson method. Outliers were identified
by the Baujat plot and leave-one-out analysis if there was considerable heterogeneity. The primary out-
come measure was survival to discharge. Secondary outcome measures included hospital length of stay,
subgroup analysis of neonatal and paediatric groups, types and duration of ECMO and complications
. RESULTS Of the 2054 articles screened, we identified 23 original articles for systematic review and
meta-analysis. Cumulative estimate of survival (13 studies, 2559 patients) in the cohort was 59% (95%CI:
51-67%). Patients had a median length of hospital stay of 28.8 days, median intensive care unit stay of
13.5 days, and median ECMO duration of 129 h. Children needing venoarterial ECMO (9 studies, 208
patients) showed overall pooled survival of 65% (95%CI: 50-80%). Neonates (< 4 weeks of age) with
sepsis needing ECMO (7 studies, 85 neonates) had pooled survival of 73% (95%CI: 56- 87%). Gram
positive organisms were the most common pathogens (47%) in septic children supported with ECMO.
CONCLUSION Survival rates of children with sepsis needing ECMO was 59%. Neonates had higher
survival rates (73%); gram positive organisms accounted for most common infections in children needing
ECMO. Despite limitations, pooled survival data from this review indicates consideration of ECMO in
refractory septic shock for all pediatric age groups.
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Abstract 
Background: The benefits of extracorporeal membrane oxygenation (ECMO) in children with sepsis remain contro-
versial. Current guidelines on management of septic shock in children recommend consideration of ECMO as salvage 
therapy. We sought to review peer-reviewed publications on effectiveness of ECMO in children with sepsis.
Methods: Studies reporting on mortality in children with sepsis supported with ECMO, published in PubMed, 
Scopus and Embase from 1972 till February 2020, were included in the review. This study was done in adherence 
to Preferred Reporting Items for Systematic Review and Meta-Analysis statement after registering the review proto-
col with PROSPERO. Study eligibility was independently assessed by two authors and disagreements resolved by a 
third author. Publications were reviewed for quality using Grading of Recommendations Assessment, Development, 
and Evaluation (GRADE) system. Random-effects meta-analyses (DerSimonian and Laird) were conducted, and 95% 
confidence intervals were computed using the Clopper-Pearson method. Outliers were identified by the Baujat plot 
and leave-one-out analysis if there was considerable heterogeneity. The primary outcome measure was survival to 
discharge. Secondary outcome measures included hospital length of stay, subgroup analysis of neonatal and paediat-
ric groups, types and duration of ECMO and complications.
Results: Of the 2054 articles screened, we identified 23 original articles for systematic review and meta-analysis. 
Cumulative estimate of survival (13 studies, 2559 patients) in the cohort was 59% (95%CI: 51–67%). Patients had a 
median length of hospital stay of 28.8 days, median intensive care unit stay of 13.5 days, and median ECMO duration 
of 129 h. Children needing venoarterial ECMO (9 studies, 208 patients) showed overall pooled survival of 65% (95%CI: 
50–80%). Neonates (< 4 weeks of age) with sepsis needing ECMO (7 studies, 85 neonates) had pooled survival of 73% 
(95%CI: 56- 87%). Gram positive organisms were the most common pathogens (47%) in septic children supported 
with ECMO.
Conclusion: Survival rates of children with sepsis needing ECMO was 59%. Neonates had higher survival rates (73%); 
gram positive organisms accounted for most common infections in children needing ECMO. Despite limitations, 
pooled survival data from this review indicates consideration of ECMO in refractory septic shock for all pediatric age 
groups.
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Background
Sepsis and septic shock remain an important cause of 
childhood mortality globally despite advances in early 
detection and appropriate management in Intensive 
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Care Units (ICUs) [1]. The World Health Assembly, the 
decision-making body of the World Health Organisation, 
adopted a recent resolution to reduce the global burden 
of sepsis through early identification, prevention and 
management [1–5]. The percentage of all global deaths in 
2017 related to sepsis was highest in neonates and chil-
dren compared to the adult population [5]. A recent sys-
tematic review revealed that nearly 1 in 4 children with 
sepsis die. Children most at risk of death are younger 
patients and those with septic shock; sepsis and infec-
tions account for 6.3 deaths of 1000 live births among 
children younger than 5 years [6].
While current best practice includes the early deliv-
ery of sepsis treatment bundles, therapeutic options 
for children refractory to initial resuscitation remain 
very limited [7]. The development of refractory shock 
is associated with a steep increase in mortality in pedi-
atric sepsis [8–11]. Previous sepsis guidelines, including 
the American College of Critical Care Medicine, recom-
mended consideration for Extracorporeal Membrane 
Oxygenation (ECMO) for persistent shock in spite of 
early fluid- and inotrope-based resuscitation [12, 13]. 
Studies have reported an increase in use of ECMO for 
pediatric septic shock with improving outcomes over 
time [14–17]. Survival rates of septic patients supported 
with ECMO are above 70% for neonates [16, 18, 19] and 
approximately 40% for older children in both single cen-
tre and registry studies. Accordingly, the 2020 Surviving 
Sepsis Campaign International Guidelines for the Man-
agement of Septic Shock and Sepsis-Associated Organ 
Dysfunction in Children recommended venoarterial 
ECMO as rescue therapy in children with septic shock 
only if refractory to all other treatments, with a low level 
of evidence and a weak recommendation [20].
These recommendations remain based on few, rela-
tively small studies. Additional challenges relate to the 
difficulties in assessing outcomes in heterogeneous 
cohorts of critically ill children and the number of fac-
tors which may contribute to outcomes, including patient 
selection, time to ECMO initiation, cannulation strate-
gies, different ECMO technology, and the experience 
of the treating team [17, 21]. As a result, the outcome 
benefits of ECMO in pediatric sepsis remain controver-
sial. We sought to systematically review the literature to 
examine survival rates of pediatric and neonatal patients 
with sepsis needing ECMO, and to describe etiologies of 
sepsis and the complication rates in published cohorts of 
neonates and children treated with ECMO for sepsis.
Methods
This study was done in adherence to the ethical guide-
lines stated in the Declaration of Helsinki following the 
Preferred Reporting Items for Systematic Review and 
Meta-Analysis (PRISMA) statement. [22] The review 
protocol was registered with PROSPERO (Ref:CRD 
42020161828).
Study selection
A comprehensive literature search was performed using 
MEDLINE, Embase and Scopus databases to retrieve 
published data from 1972 up to  15th February 2020 
on the use of ECMO in neonatal and pediatric sep-
tic patients. The search phrases for the three databases 
included Boolean terms ‘AND’ and ‘OR’ with the follow-
ing keywords in various possible combinations: “ECMO”, 
“extracorporeal membrane oxygenation”, “ECLS”, “Infant”, 
“newborn”, “neonatal”, “pediatric”, “sepsis”, and “infec-
tion” [Additional file  1: eTable  1]. In addition, a hand 
search of all relevant studies and their citation lists 
was performed to identify additional articles for inclu-
sion. Articles were selected for systematic review if 
they described neonatal and/or pediatric septic patients 
undergoing venoarterial and venovenous ECMO and the 
incidence of mortality was clearly stated. No restriction 
was placed on study type (prospective or retrospective). 
For studies that included overlapping patients (period 
of overlap > 1 year), the largest study was included in the 
meta-analysis while the rest of the studies were included 
in the review. We excluded studies with predominantly 
patients above 18  years old, articles with fewer than 
5 patients, articles not written in English, conference 
abstracts, surveys and articles without full text, review 
articles and case reports. Publications from the Extracor-
poreal Life Support Organization (ELSO) International 
registry were excluded since data on patients reported 
to the ELSO Registry are likely also reported to national 
databases and present in single center reviews and thus 
potentially duplicated. Studies based on national regis-
ters were included provided there was no overlap with 
single-center studies. The eligibility of studies was inde-
pendently assessed by two review authors (NY and KR) 
and disagreements were resolved by consensus or appeal 
to a third author (GM). Publications were reviewed for 
quality using the Joanna Briggs Institute (JBI) checklist 
for prevalence studies [23] as well as the Grading of Rec-
ommendations Assessment, Development, and Evalua-
tion (GRADE) system to the determine the overall rating 
confidence in the body of evidence [24]. Case reports and 
case series (< 5 patients) were excluded due to likelihood 
of positive outcome bias.
Study analysis
Data including study design, outcomes, patient charac-
teristics, and interventions were extracted independently. 
Neonates were defined as children 28 days or less of age. 
Descriptive statistics, such as the medians and 25th to 
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75th percentiles were reported for continuous variables, 
and the counts and percentages were reported for cate-
gorical variables. Survival to discharge was the primary 
measure of outcome in our meta-analysis. Secondary 
outcome measures included hospital length of stay, types 
and duration of ECMO and complications. Subgroup 
analysis were also performed for the neonatal and pedi-
atric age group.
We anticipated heterogeneity between studies. To 
account for the variability between studies in the meta-
analysis, we used the random-effects model that was 
based on the inverse variance method where the DerSi-
monian and Laird method [25] was used to estimate the 
between-study variance. Briefly for the meta-analysis 
of proportions, exact confidence interval (CI) for each 
proportion was computed using the Clopper-Pearson 
method [26]. A variance-stabilizing transformation, 
called the Freeman-Tukey double arcsine transformation 
[27], was applied to all proportions and the meta-analy-
sis was performed on the transformed proportions. The 
pooled transformed proportion and its 95%CI were back 
transformed to obtain pooled estimates on the original 
proportion scale. To obtain a pooled mean age of study 
participants across studies, studies that did not report the 
mean and/or its corresponding standard deviation (SD) 
had these quantities estimated from the reported medi-
ans, range, and IQR using the methods proposed by Wan 
et al. [28].
Statistical heterogeneity between studies was identi-
fied using I2 statistics, where I2 ≤ 40%, between 30–60%, 
between 50–75% and ≥ 75% indicated low, moderate, 
substantial, and considerable heterogeneity, respectively. 
P values for  I2 statistic were derived from the chi-square 
distribution of Cochran’s Q test. Together with the visual 
inspection of the forest plot, additional diagnostics were 
carried out to identify outlying or/and influential studies. 
Firstly, studies with studentized deleted residuals greater 
than 1.96 or less than -1.96 were identified as potential 
outliers [29]. Next, a set of leave-one-out analysis was 
performed to identify potential influential studies that 
resulted in a large change in the pooled estimates after 
they were left out one at a time from all studies. Lastly, 
a Baujat plot was used to identify studies that had high 
contributions to the heterogeneity in the meta-analytic 
data [30]. With these diagnostics, an agreement was 
made between two investigators to identify and remove 
outlying/influential studies. A funnel plot and Egger’s 
tests was conducted to assess for reporting publication 
bias. Univariate meta regression analysis was also con-
ducted on pre-ECMO characteristics where at least 4 
data points were available. The analyses were conducted 
using the R Studio (Version 3.6.1, R Studio, Inc. Boston) 
using the ‘metafor’ and ‘meta’ packages.
Results
Of the 2054 articles screened, we identified 23 obser-
vational studies for systematic review and meta-anal-
ysis [3, 14, 15, 17, 31–48] (Table 1 and Additional file 1: 
Fig. 1); fifteen articles had overlapping information. Ten 
articles (6 from Australia, 1 from UK, 1 from Taiwan, 1 
from USA, and 1 Multi regional) were excluded from the 
meta-analysis to best represent the population in terms 
of the period of study and setting, with minimal data loss 
and overlap. The definition of sepsis and septic shock was 
variable; most centers followed institutional or interna-
tional guidelines to define criteria for ECMO initiation. 
Characteristics of the 13 retrospective studies included 
in the meta-analysis are summarized in Additional file 1: 
eTables 2, 3, and 4. The number of patients ranged from 7 
to 1358 per study.
Primary outcome
Thirteen studies (Additional file  1: eTable  2) reported 
2559 paediatric and neonatal patients with sepsis who 
needed ECMO support. The overall pooled estimate 
of survival in the cohort was 59% (95%CI: 51% to 67%, 
p < 0.01) (Fig.  1). There was considerable heterogeneity 
amongst the studies; we identified three studies [31, 32, 
46] that were outliers or influential with the leave one out 
analysis and the Baujat plot. After excluding the three 
studies, the remaining 10 studies had 2486 patients with 
a cumulative pooled estimate survival of 55% (95% CI 
49% to 62%, p < 0.01) (Additional file 1: Fig. 2).
Secondary outcomes
Children (0–18  years) with sepsis needing ECMO sup-
port had a median length of hospital stay of 28.8  days 
(IQR: 13–35.5  days), a median ICU stay of 13.5  days 
(IQR: 9.75–26.3 days), and a median ECMO duration of 
129 h (IQR: 86.3–203.8 h). Three studies reported on the 
duration of ICU care prior to ECMO initiation which was 
34  h (IQR: 8–96), 12  h (SD 13.4) and 7  h, respectively. 
Two studies [15, 44] reported on duration of septic shock 
before ECMO which was 29.5 h (IQR: 20–46) and 22 h 
(IQR: 6.5–38) respectively.
Subgroup analysis
The pooled survival in each region was 73% (95% CI: 60% 
to 85%, p < 0.01) (n = 2306) in North America, 48% (95% 
CI: 36% to 61%, p = 0.04) (n = 199) in Australasia and 52% 
(95% CI: 38% to 66%, p = 0.58) (n = 54) in Europe. (Addi-
tional file 1: Figs. 3,4,5).
Use of venoarterial ECMO was identified in 9 stud-
ies with 208 patients (95% CI: 50% to 80%, p < 0.01) and 
a cumulative survival of 65%. (Fig. 2) 9 of these patients 
were initially started with venoarterial ECMO and had 
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Table 1 List of 23 articles included in systemic review and meta-analysis that reported on children with sepsis needing 
ECMO
Abbreviations: VA: Venoarterial, VV: Venovenous, Peripheral and Central refers to the type of cannulation for ECMO. P: pediatric Patients, N: Neonates, Data presented 
as mean ± SD, median (25th to 75th percentile), or median [range]. 1: Patients with ECMO-Only. 2 Patients with ECMO + RRT 
S2tudy author Year Sample Size Age (mean/
median), (IQR, 
SD)
% male Type of ECMO Country/location
C. W. Lillehei et al 1989 8 Not Stated Not Stated Not Specified USA (Children’s Hospital Boston)
S. McCune et al 1990 10 80hrs (37) Not Stated 10 VA USA (Children’s National Medical Center)
J. R. Hocker et al 1992 15 Not Stated Not Stated Not Specified USA (Kosair Children’s Hospital)
D. Cochrane et al 1992 5 Not Stated Not stated 5 VA Australia (The Royal Children’s Hospital)
M. Nagaya et al 1993 7 0.74y (0.7–0.8) Not Stated 7 VA Japan (Central Hospital, Aichi)
J. Beca and W. Butt 1994 9 12y (0.2–15) 56 9 VA Australia (The Royal Children’s Hospital)
A.P. Goldman et al 1997 12 Not Stated Not Stated 10 VA, 2VV Multi-center (Australia and UK)
D. K. Luyt et al 2004 11 1y (0.8–1.3) Not Stated 7 VA, 4VV UK (Glenfield Hospital, Leicester)
G. MacLaren et al 2007 45 2.5y (0.4–9) 62 45 VA Australia (The Royal Children’s Hospital)
R. Tiruvoipati et al 2007 6 4y (0.17–14) Not stated 2 VA, 4 VV UK (Glenfield Hospital, Leicester)
S. J. Wu et al 2007 8 4.3y (2.9–63) 50 5 VA, 3 VV Taiwan (Mackay Memorial Hospital)






Australia (The Royal Children’s Hospital)
G. MacLaren et al 2011 23 6y (2.8–12.3) 57 23 Central VA Australia (The Royal Children’s Hospital)
C. C. Peng et al 2012 12 4.7y (3.1) 58 8 VA, 4VV Taiwan (Mackay Memorial Hospital)
Y. Kawai et al 2015 14 12y (4.2–15) 64 13 VA, 1 VV USA (University of Michigan)
J. Rambaud et al 2015 22 2.5y (3.1) 64 22 VA France (Armand-Trousseau Hospital)
A. Ruth et al 2015 1,858 1.1y (0.2–6.7)1 53 Not Specified USA (Pediatric healthcare information system)
K. Y. Chen et al 2016 7 3.9y (0.4–12.8)2
Not Stated
Not Stated Not Stated Australia (Royal Children’s Hospital and Monash Medical 
Center)
A. Sole et al 2018 21 3.3y (0.7–4.7) P
1 day (1–5) N
62 21 VA Spain (Hospital Sant Joan de Deu)
F. Oberender et al 2018 44 3.6y (0.5–8.0) 52 44 VA Australia, New Zealand, Netherlands, UK, USA
T. H. Chang et al 2018 55 7.2y (6.2) 53 Not Specified Taiwan (National Taiwan University Children’s Hospital)
K. Robb et al 2019 415 Not Stated Not stated Not specified USA (National Inpatient Sample)
L.J. Schlapbach et al 2019 80 1.3y (0.1–7.0) 61 23 Peripheral VA Australia & New Zealand (ANZPIC Registry)
57 Central VA
Fig. 1 Forest plot of studies reporting on use of ECMO in children with sepsis
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been switched to venovenous ECMO during the ECMO 
run. After removal of 2 potential outliers [31, 32], analysis 
of the remaining 7 studies yielded a pooled survival rate 
of 53% (95%CI: 45% to 60%, p = 0.46). (Additional file 1: 
Fig. 6).
6 studies presented data on 138 pediatric patients aged 
between 28  days and 18  years with an overall pooled 
survival of 50% (95% CI: 41% to 59%, p = 0.81) (Fig. 3). 7 
studies reported on 85 neonates with septic shock need-
ing ECMO; overall pooled survival rate was 73% (95% CI: 
56% to 87%, p = 0.03). After removal of 1 outlier study 
[32], 6 studies reported on 75 neonates with an overall 
pooled survival of 66% (95% CI: 54% to 77%, p = 0.41) 
(Additional file 1: Fig. 7a and b).
Univariate meta regression analysis was also conducted 
on pre-ECMO characteristics where at least 4 data points 
were available: there was no significant association found 
between survival and pre-ECMO lactate levels, Car-
diac Arrest (%), need for renal replacement therapy (%), 
ECMO duration, overall length of stay in hospital and 
overall length of stay in ICU. (Table 2) (Additional file 1: 
Figs. 8–13).
Data on use of central ECMO and survival to dis-
charge was reported in 3 studies from Australia/
New Zealand. Horton et  al. (n = 12), MacLaren et  al. 
(n = 23) and Schlapbach et al. (n = 57) reported a sur-
vival rate of 75%, 73% and 61% respectively for pedi-
atric patients with septic shock who had atrio-aortic 
cannulation. The papers published by Horton et  al. 
and MacLaren et  al. were from the same institution 
with slightly overlapping time periods.
Fig. 2 Forest plot of studies reporting on use of Venoarterial ECMO in children with sepsis
Fig. 3 Forest plot of Pediatric group of patients needing ECMO in sepsis
Table 2 Meta-regression table of Potential Modifiers
Risk factors studied No. of studies P-value regression 
coefficient 
[β]
Hospital Length of Stay 5 0.87 − 0.0009
ICU Length of Stay 6 0.73 − 0.0009
Pre-ECMO Factors
CPR 5 0.51 − 0.0025
% Renal Replacement Therapy 7 0.77 0.0003
Lactate 4 0.89 − 0.0019
ECMO Factors
ECMO duration 8 0.96 0.022
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Complications
A total of 23 studies (Additional file  1: Table  2) which 
included overlapping studies and studies included in the 
meta-analysis were used in descriptive analysis of other 
outcomes. 14 studies presented data on complications 
from a total of 246 patients. The pooled rate of complica-
tions was 31% (95% CI: 19% to 44%); out of 67 reported 
complications, 40 (60%) were hemorrhagic, 14 (21%) 
were neurologic, 8 (12%) were vascular, 3 (5%) were renal, 
1 (1%) was cardiovascular and 1 (1%) was infectious. 6 
studies reported data on mechanical and circuit compli-
cations (e.g. circuit clotting, oxygenation failures, pump 
and heat exchanger malfunction and air in circuits) with 
a pooled complication rate of 46% (95% CI: 31%–62%).
Microbiological etiology
13 studies (n = 316) reported on the microbiological eti-
ology of sepsis. Out of the 258 organisms cultured, gram 
positive organisms accounted for 47% (n = 121), followed 
by gram negative organisms at 38% (n = 99), viral infec-
tions at 14% (n = 35) and fungal infections 1% (n = 3). 
Neisseria meningitidis, Staphylococcus aureus, and Strep-
tococcus pneumoniae were the most common organisms 
isolated.
Risk of bias
All of the 13 studies that were assessed through the JBI 
checklist were good quality with minimum high score of 
8/9 with no concerns on risk of bias. Egger’s test and fun-
nel plots showed some evidence of publication bias in the 
total ECMO group which was resolved after removal of 
influential studies (Additional file  1: Fig.  14). There was 
no evidence of publication bias in the VA-ECMO, pediat-
ric ECMO and neonatal ECMO groups: Additional file 1: 
Figs. 15, 16, 17 respectively) (Additional file 1: eTable 5). 
The GRADE system showed high level of certainty in the 
use of ECMO in pediatric and neonatal and venoarterial 
ECMO groups and a moderate level of certainty in the 
overall use of ECMO in children with sepsis (Table 3).
Discussion
The use of ECMO in pediatric sepsis has increased over 
the past decade [49] with variable survival rates [49–51]. 
Our meta-analysis of observational studies showed that 
overall survival rates of children with sepsis treated with 
ECMO were 59%. Neonates had higher survival rates 
(73%). Gram positive organisms were the most common 
type of pathogen.
The hemodynamic manifestations of septic shock can 
vary between different age groups. While early-onset sep-
sis may present predominantly as right heart dysfunction 
from persistent pulmonary hypertension of the newborn 
(PPHN), older infants and young children often manifest 
severe left ventricular dysfunction. Older children and 
adults more commonly present with distributive shock 
[15]. The role of ECMO in the management of refractory 
septic shock in neonates and children stems by virtue of 
its ability to provide perfusion of oxygenated blood to tis-
sues and maintain gas exchange even in refractory car-
diopulmonary failure. However, the specific threshold 
as to when shock, or multi-organ dysfunction should be 
considered “refractory”, remains poorly defined. Some 
data indicate that venoarterial ECMO is associated with 
better survival than conventional therapy in children 
with septic shock if high ECMO flows (> 150 mL/kg/min) 
can be provided [20, 45]. While data on ECMO flows 
were not available in all the studies included in this meta-
analysis, our analysis of neonatal and pediatric septic 
patients who needed venoarterial (VA) ECMO showed 
an overall pooled survival of 63%; subsequent removal of 
outlier studies yielded an overall pooled survival of 53%. 
Children who underwent central ECMO cannulation 
have been shown to have survival rates up to 73% in sin-
gle centre studies [17]. In comparison, the ELSO registry 
reported survival rates for pediatric patients with sepsis 
supported on ECMO of 52% [49].
The American College of Critical Care Medicine guide-
lines for hemodynamic support of pediatric and neona-
tal septic shock recommends ECMO as the therapy of 
choice for newborn patients with refractory PPHN and 
sepsis with Level 1 C evidence; however the guidelines 
highlight an expected survival with ECMO for septic 
shock being no greater than 50% in children, with Level 
2 C evidence for consideration of ECMO in this group 
[18]. The recently published Surviving Sepsis Campaign 
International Guidelines in children suggested veno-
venous ECMO for children with sepsis induced respira-
tory distress syndrome and refractory hypoxia as well as 
venoarterial ECMO as a rescue therapy in children with 
septic shock refractory to all other treatments. The rec-
ommendations for both above were weak based on very 
low quality of evidence [20]. Our meta-analysis supple-
ment the above recommendations and showed survival 
rates above 50% in septic children and more than 70% in 
neonatal sepsis with moderate to high level of certainty in 
the level of evidence.
There are several limitations to the study. This review 
is based on non-randomized or non-propensity-matched 
studies, and the studies selected for analysis showed 
moderate heterogeneity. The challenges of interpreting 
the heterogeneity using I2 values has been highlighted 
when studies with large sample sizes result in very nar-
row confidence intervals. It has also been established 
that I2 for the pooled estimate can be high even in the 
presence of modest inconsistency and can be misleading 



































Table 3 Qualitative assessment of results of metanalysis for use of ECMO in children with sepsis (GRADE analysis)
a There was considerable amount of heterogenity of  I2 = 62% even after statistical removal of potential outliers that could have contributed to heterogenity, likely explained by the differences in age groups( neonate Vs 
pediatric), sample size and variability in JBI scores
№ of studies Certainty assessment Effect Certainty Importance
Study design Risk of bias Inconsistency Indirectness Imprecision Other 
considerations



















Not serious Not serious Not serious Not serious None 118 208 0.65 (0.50 to 
0.80)
⊕⊕⊕⊕ HIGH CRITICAL













Not serious Not serious Not serious Not serious None 59 85 0.73 (0.56 to 
0.87)
⊕⊕⊕⊕ HIGH CRITICAL
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sample sizes and reporting patterns likely add to the het-
erogeneity in our cohort. The results obtained should 
be interpreted in light of this heterogeneity; even if the 
heterogeneity was accounted for via use of the random-
effects model [53–55]. The diagnostic criteria of refrac-
tory septic shock varied between studies, only a handful 
of studies reported the use of the 2005 pediatric Sepsis 
Consensus Conference Criteria [56] while some reported 
using the International Classification of Diseases (ICD-9) 
to define septic shock and most of the papers diagnosed 
septic shock based on their institutional guidelines. An 
international multicentre study based on a Delphi pro-
cess followed by data-driven derivation and validation 
defined refractory septic shock in children as the combi-
nation of severe cardiovascular dysfunction (measured by 
poor cardiac function and/or preceding cardiac arrest), 
high lactate, and high vasopressor requirements (meas-
ured by vasopressor-inotrope score) [11]. Unfortunately, 
the data provided in the studies included in this meta-
nalysis would not allow to verify if the proposed refrac-
tory septic shock criteria were met. The timing of ECMO 
initiation in children with sepsis could not be assessed 
with certainty from the literature, although one recent 
multicentre cohort study concluded that ECMO was only 
of benefit if the predicted risk of death was > 50% (48). 
The studies included in our analysis spanned from 1992 
to 2020, where sepsis diagnosis, sepsis management, 
ECMO technology and ECMO practice have undergone 
substantial changes. Also, meta-regression analyses are 
inherently constrained by a lack of power, resulting in 
an increased risk of Type 2 errors suggesting that lack 
of significant association does not imply that a correla-
tion does not exist [57]. However, this remains the larg-
est available cohort of patients which has been analysed 
so far; there was no evidence of publication bias and 
the methodological quality of all the studies included 
in our analysis scored high (> 8/9), using the JBI critical 
appraisal tool (Additional file  1: Table  6). The GRADE 
analysis demonstrated moderate to high certainty in the 
evidence presented in this paper.
Conclusion
The use of ECMO to resuscitate and support children 
with sepsis and refractory shock is feasible and is asso-
ciated with survival rates as high as 59%. Neonates had 
higher survival rates and central cannulation may be 
associated with better outcomes in children needing 
ECMO with sepsis. Despite the limitations of studies 
included in this metanalysis, the aggregate data indicate 
that survival for patients treated with septic shock overall 
justifies recommendation to consider ECMO in refrac-
tory septic shock for all pediatric age groups. Future stud-
ies should provide more evidence to inform on timing 
and thresholds for ECMO initiation, including dynamic 
assessment of response to therapy/deterioration.
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